Literature DB >> 28102076

Kinobead and Single-Shot LC-MS Profiling Identifies Selective PKD Inhibitors.

Martin Golkowski1, Rama Subba Rao Vidadala1, Chloe K Lombard1, Hyong Won Suh1, Dustin J Maly1, Shao-En Ong1.   

Abstract

ATP-competitive protein kinase inhibitors are important research tools and therapeutic agents. Because there are >500 human kinases that contain highly conserved active sites, the development of selective inhibitors is extremely challenging. Methods to rapidly and efficiently profile kinase inhibitor targets in cell lysates are urgently needed to discover selective compounds and to elucidate the mechanisms of action for polypharmacological inhibitors. Here, we describe a protocol for microgram-scale chemoproteomic profiling of ATP-competitive kinase inhibitors using kinobeads. We employed a gel-free in situ digestion protocol coupled to nanoflow liquid chromatography-mass spectrometry to profile ∼200 kinases in single analytical runs using as little as 5 μL of kinobeads and 300 μg of protein. With our kinobead reagents, we obtained broad coverage of the kinome, monitoring the relative expression levels of 312 kinases in a diverse panel of 11 cancer cell lines. Further, we profiled a set of pyrrolopyrimidine- and pyrazolopyrimidine-based kinase inhibitors in competition-binding experiments with label-free quantification, leading to the discovery of a novel selective and potent inhibitor of protein kinase D (PKD) 1, 2, and 3. Our protocol is useful for rapid and sensitive profiling of kinase expression levels and ATP-competitive kinase inhibitor selectivity in native proteomes.

Entities:  

Keywords:  SILAC; kinase inhibitor; kinobeads; protein kinase D; proteomics; target identification

Mesh:

Substances:

Year:  2017        PMID: 28102076      PMCID: PMC5663466          DOI: 10.1021/acs.jproteome.6b00817

Source DB:  PubMed          Journal:  J Proteome Res        ISSN: 1535-3893            Impact factor:   4.466


  54 in total

Review 1.  The protein kinase complement of the human genome.

Authors:  G Manning; D B Whyte; R Martinez; T Hunter; S Sudarsanam
Journal:  Science       Date:  2002-12-06       Impact factor: 47.728

2.  Stable-isotope dimethyl labeling for quantitative proteomics.

Authors:  Jue-Liang Hsu; Sheng-Yu Huang; Nan-Haw Chow; Shu-Hui Chen
Journal:  Anal Chem       Date:  2003-12-15       Impact factor: 6.986

3.  Comprehensive analysis of kinase inhibitor selectivity.

Authors:  Mindy I Davis; Jeremy P Hunt; Sanna Herrgard; Pietro Ciceri; Lisa M Wodicka; Gabriel Pallares; Michael Hocker; Daniel K Treiber; Patrick P Zarrinkar
Journal:  Nat Biotechnol       Date:  2011-10-30       Impact factor: 54.908

4.  Systematic evaluation of label-free and super-SILAC quantification for proteome expression analysis.

Authors:  Andreas Tebbe; Martin Klammer; Stefanie Sighart; Christoph Schaab; Henrik Daub
Journal:  Rapid Commun Mass Spectrom       Date:  2015-05-15       Impact factor: 2.419

5.  Identifying the proteins to which small-molecule probes and drugs bind in cells.

Authors:  Shao-En Ong; Monica Schenone; Adam A Margolin; Xiaoyu Li; Kathy Do; Mary K Doud; D R Mani; Letian Kuai; Xiang Wang; John L Wood; Nicola J Tolliday; Angela N Koehler; Lisa A Marcaurelle; Todd R Golub; Robert J Gould; Stuart L Schreiber; Steven A Carr
Journal:  Proc Natl Acad Sci U S A       Date:  2009-03-02       Impact factor: 11.205

Review 6.  FDA-approved small-molecule kinase inhibitors.

Authors:  Peng Wu; Thomas E Nielsen; Mads H Clausen
Journal:  Trends Pharmacol Sci       Date:  2015-05-12       Impact factor: 14.819

7.  In situ kinase profiling reveals functionally relevant properties of native kinases.

Authors:  Matthew P Patricelli; Tyzoon K Nomanbhoy; Jiangyue Wu; Heidi Brown; David Zhou; Jianming Zhang; Subadhra Jagannathan; Arwin Aban; Eric Okerberg; Chris Herring; Brian Nordin; Helge Weissig; Qingkai Yang; Jiing-Dwan Lee; Nathanael S Gray; John W Kozarich
Journal:  Chem Biol       Date:  2011-06-24

8.  Development of Toxoplasma gondii calcium-dependent protein kinase 1 (TgCDPK1) inhibitors with potent anti-toxoplasma activity.

Authors:  Steven M Johnson; Ryan C Murphy; Jennifer A Geiger; Amy E DeRocher; Zhongsheng Zhang; Kayode K Ojo; Eric T Larson; B Gayani K Perera; Edward J Dale; Panqing He; Molly C Reid; Anna M W Fox; Natascha R Mueller; Ethan A Merritt; Erkang Fan; Marilyn Parsons; Wesley C Van Voorhis; Dustin J Maly
Journal:  J Med Chem       Date:  2012-02-27       Impact factor: 7.446

9.  Mass spectrometry based method to increase throughput for kinome analyses using ATP probes.

Authors:  F E McAllister; M Niepel; W Haas; E Huttlin; P K Sorger; S P Gygi
Journal:  Anal Chem       Date:  2013-04-22       Impact factor: 6.986

10.  Protocol for micro-purification, enrichment, pre-fractionation and storage of peptides for proteomics using StageTips.

Authors:  Juri Rappsilber; Matthias Mann; Yasushi Ishihama
Journal:  Nat Protoc       Date:  2007       Impact factor: 13.491

View more
  20 in total

1.  How ATP-Competitive Inhibitors Allosterically Modulate Tyrosine Kinases That Contain a Src-like Regulatory Architecture.

Authors:  Linglan Fang; Jessica Vilas-Boas; Sujata Chakraborty; Zachary E Potter; Ames C Register; Markus A Seeliger; Dustin J Maly
Journal:  ACS Chem Biol       Date:  2020-06-23       Impact factor: 5.100

Review 2.  Kinase inhibitors: the road ahead.

Authors:  Fleur M Ferguson; Nathanael S Gray
Journal:  Nat Rev Drug Discov       Date:  2018-03-16       Impact factor: 84.694

3.  Targeting Dynamic ATP-Binding Site Features Allows Discrimination between Highly Homologous Protein Kinases.

Authors:  Sujata Chakraborty; Takayuki Inukai; Linglan Fang; Martin Golkowski; Dustin J Maly
Journal:  ACS Chem Biol       Date:  2019-05-13       Impact factor: 5.100

4.  Development of a Chemical Toolset for Studying the Paralog-Specific Function of IRE1.

Authors:  Hannah C Feldman; Venkata Narayana Vidadala; Zachary E Potter; Feroz R Papa; Bradley J Backes; Dustin J Maly
Journal:  ACS Chem Biol       Date:  2019-10-14       Impact factor: 5.100

5.  7 H-Pyrrolo[2,3- d]pyrimidin-4-amine-Based Inhibitors of Calcium-Dependent Protein Kinase 1 Have Distinct Inhibitory and Oral Pharmacokinetic Characteristics Compared with 1 H-Pyrazolo[3,4- d]pyrimidin-4-amine-Based Inhibitors.

Authors:  Rama S R Vidadala; Martin Golkowski; Matthew A Hulverson; Ryan Choi; Molly C McCloskey; Grant R Whitman; Wenlin Huang; Samuel L M Arnold; Lynn K Barrett; Erkang Fan; Ethan A Merritt; Wesley C Van Voorhis; Kayode K Ojo; Dustin J Maly
Journal:  ACS Infect Dis       Date:  2018-03-16       Impact factor: 5.084

6.  A Combined Approach Reveals a Regulatory Mechanism Coupling Src's Kinase Activity, Localization, and Phosphotransferase-Independent Functions.

Authors:  Ethan Ahler; Ames C Register; Sujata Chakraborty; Linglan Fang; Emily M Dieter; Katherine A Sitko; Rama Subba Rao Vidadala; Bridget M Trevillian; Martin Golkowski; Hannah Gelman; Jason J Stephany; Alan F Rubin; Ethan A Merritt; Douglas M Fowler; Dustin J Maly
Journal:  Mol Cell       Date:  2019-04-04       Impact factor: 17.970

7.  Kinome chemoproteomics characterization of pyrrolo[3,4-c]pyrazoles as potent and selective inhibitors of glycogen synthase kinase 3.

Authors:  Martin Golkowski; Gayani K Perera; Venkata Narayana Vidadala; Kayode K Ojo; Wesley C Van Voorhis; Dustin J Maly; Shao-En Ong
Journal:  Mol Omics       Date:  2018-02-12

8.  Pharmacoproteomics Identifies Kinase Pathways that Drive the Epithelial-Mesenchymal Transition and Drug Resistance in Hepatocellular Carcinoma.

Authors:  Martin Golkowski; Ho-Tak Lau; Marina Chan; Heidi Kenerson; Venkata Narayana Vidadala; Anna Shoemaker; Dustin J Maly; Raymond S Yeung; Taranjit S Gujral; Shao-En Ong
Journal:  Cell Syst       Date:  2020-08-04       Impact factor: 10.304

9.  Advances in bumped kinase inhibitors for human and animal therapy for cryptosporidiosis.

Authors:  Matthew A Hulverson; Ryan Choi; Samuel L M Arnold; Deborah A Schaefer; Andrew Hemphill; Molly C McCloskey; Dana P Betzer; Joachim Müller; Rama S R Vidadala; Grant R Whitman; Kasey L Rivas; Lynn K Barrett; Robert C Hackman; Melissa S Love; Case W McNamara; Thomas K Shaughnessy; Alison Kondratiuk; Matthew Kurnick; Patricia N Banfor; James J Lynch; Gail M Freiberg; Dale J Kempf; Dustin J Maly; Michael W Riggs; Kayode K Ojo; Wesley C Van Voorhis
Journal:  Int J Parasitol       Date:  2017-09-09       Impact factor: 3.981

Review 10.  Protein kinase D signaling in cancer: A friend or foe?

Authors:  Adhiraj Roy; Jing Ye; Fan Deng; Qiming Jane Wang
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2017-05-31       Impact factor: 10.680

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.